Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gruppo Oncologico dell'Italia Meridionale (GOIM) is a prominent Italian non-profit academic research organization (ARO) specializing in clinical oncology research. Established in 1991, the group coordinates a vast network of oncology departments across Southern Italy to conduct multicenter clinical trials. GOIM's research portfolio covers a broad spectrum of malignancies, including gastrointestinal, lung, and breast cancers, with a focus on optimizing treatment protocols and evaluating new therapeutic agents. The organization plays a critical role in the Italian medical community by bridging the gap between clinical practice and innovative research, frequently collaborating with pharmaceutical partners for investigator-initiated studies. Their work is widely published in international peer-reviewed journals, contributing significantly to the global understanding of cancer management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gruppo Oncologico dell'Italia Meridionale.